Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
CEO of molecular diagnostics firm Qiagen steps down after decades of service; Halma division chief steps up to medical and environmental sector chief exec; and more.
Angel Medical Systems, makers of an implantable cardiac monitoring system, has assembled a medical advisory board; electroceutical therapy firm Endonovo Therapeutics has hired a strategic adviser as its CEO; and more.
AstraZeneca’s chief scientist moved over to cancer diagnostics firm Oncimmune; JenaValve, developer of a heart valve replacement system, hired a new VP of operations; Becton Dickinson & Co. has moved forward with a CEO succession plan; and more.
Thomas Polen will take over as CEO of Becton Dickinson & Co. on 28 January 2020 when the current CEO, Vincent Forlenza, retires. See what Thomas Polen, who is the current COO of Becton Dickinson, said about it here.
Polen led BD’s $24bn acquisition of Bard in 2017 and the $12bn acquisition of CareFusion in 2015. Forlenza has been with BD for almost 40 years, including eight as CEO.
Cirtec and Halma, the medical device contract manufacturer and hazard technology companies, have hired new chief technology officers; a former Merck head of new business is now CEO of Italian multinational firm Menarini Group; and more.
Quest Diagnostics and SomaLogic, a protein biomarker discovery and diagnostics company, will each bring on a new chief commercial officer; Immunexpress, a sepsis diagnostics firm, hired a VP for market development and commercial operations; and more.
CFO of neurovascular device-maker Penumbra adds president title to job description; PerkinElmer promotes COO to CEO; chronic liver disease management company Echosens poaches AxoGen exec for North America CEO spot; and more.
Execs On The Move: Changes In Finance Talent At Fresenius And ViroGates; Medtronic Announces New Prez
Dialysis products and services company Fresenius Medical Care and prognostic biomarker products firm ViroGates have new chief financial officers. And as part of its planned leadership succession, Medtronic announces its new president.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.